Business Potential for Agricultural Biotechnology - Asian Productivity ...
Business Potential for Agricultural Biotechnology - Asian Productivity ...
Business Potential for Agricultural Biotechnology - Asian Productivity ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
– 11 –<br />
Summary of Findings<br />
stantially with greater demands <strong>for</strong> quality produce free from pesticides and other toxic residues<br />
amidst growing public concern about sustainability. Excessive and indiscriminate use of agrochemicals<br />
resulting deteriorating soil health has led to reduced profitability from agriculture in<br />
spite of the development of high-yielding varieties and superior agrotechnologies. The gaps between<br />
expected and actual yields from best agropractices continue to widen, <strong>for</strong>cing farmers<br />
towards urbanization. The major causes are deterioration in soil structure and texture, deficiency<br />
in soil micro-flora and -fauna, and nutritional imbalances. Emphasis is now being placed on<br />
overcoming this situation by managing nutritional and biological stresses through organic, cultural,<br />
and biological means. Here biofertilizers and biopesticides may play a significant role.<br />
The area under organic cultivation has increased substantially and is presently estimated to<br />
be more than 100,000 hectares (certified); it is expected to expand at a faster rate in the coming<br />
years. This will require biological sources as nutritional and pesticide input supplements, and<br />
thus there will be a significant demand <strong>for</strong> biofertilizer and biopesticide products. In 1983, 100<br />
metric tons of biofertilizer was produced in India; by 2002–03 production had increased almost<br />
100-fold, to 90,000 metric tons. Currently there are 126 biofertilizer units engaged in biofertilizer<br />
production, and the government has extended financial assistance to 73 biofertilizer units <strong>for</strong><br />
commercial production. The use of biopesticides and biocontrol agents in India is on the increase,<br />
but not to the desired level of growth, although presently a decrease in chemical pesticide consumption<br />
is indicated. Many small entrepreneurs are developing biopesticides and biocontrol<br />
agent products, but many of them have little quality consciousness. Success stories of biopesticides<br />
in India include control of diamondback moths by Bacillus thuringiensis, control of<br />
mango hoppers, mealy bugs, and coffee pod borers by Beauveria, control of Helicoverpa on<br />
cotton, pigeon-pea, and tomato by Bacillus thuringiensi, control of white fly on cotton by neem<br />
products, control of sugarcane borers by Trichogramma, and control of rots and wilts in various<br />
crops by Trichoderma-based products.<br />
There is a large market potential <strong>for</strong> biofertilizer and biopesticide products that can only be<br />
tapped through a better understanding of rural markets and product/marketing constraints. To<br />
achieve these objectives, an extensive research and development ef<strong>for</strong>t in areas pertaining to<br />
production, quality assurance, field application, and knowledge transmission of biocontrol products<br />
is of great importance.<br />
<strong>Potential</strong> <strong>for</strong> Agribiotechnology Products in India<br />
The estimated size of the Indian biotech industry is over INR2,305 billion. Specific advantages<br />
include low operational costs, low-cost technologies, a skilled human resource base, a<br />
large network of research labs, and an abundance of raw materials in the <strong>for</strong>m of plant, animal,<br />
and human genetic diversity. <strong>Biotechnology</strong> as a business segment <strong>for</strong> India has the potential of<br />
generating USD5 billion in revenues and creating one million jobs through products and services<br />
by 2010. Biopharmaceuticals alone have the potential to be a USD2 billion market opportunity,<br />
largely driven by vaccines and biogenerics. Clinical development services can generate in excess<br />
of USD1.5 billion, while bioservices or outsourced research services can garner a market of<br />
USD1 billion over this time period. The balance of USD500 million is attributable to agricultural<br />
and industrial biotechnology.<br />
India has a strong pool of scientists and engineers, vast institutional networks, and costeffective<br />
manufacturing. There are over a hundred national research laboratories employing<br />
thousands of scientists. There are more than 300 college-level educational and training institutes<br />
across the country offering degrees and diplomas in biotechnology, bioin<strong>for</strong>matics, and the biological<br />
sciences, producing nearly 500,000 students on an annual basis. About 300,000 postgraduates<br />
and 1,500 Ph.D.s qualify in biosciences and engineering each year.<br />
The National Science and Technology Policy and the Vision Statement on <strong>Biotechnology</strong><br />
issued by the Department of <strong>Biotechnology</strong> have mandated significant interventions in the<br />
public and private sectors to foster life sciences and biotechnology. There has been substantial